Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gefitinib-loaded starch nanoparticles for battling lung cancer: Optimization by full factorial design and in vitro cytotoxicity evaluation
Haitham Amin, Shaaban K. Osman, Ahmed Mohammed, et al.
Saudi Pharmaceutical Journal (2022) Vol. 31, Iss. 1, pp. 29-54
Open Access | Times Cited: 18

Showing 18 citing articles:

Harnessing the Power of Stimuli‐Responsive Nanoparticles as an Effective Therapeutic Drug Delivery System
Mahak Fatima, Waleed Hassan Almalki, Tasneem Khan, et al.
Advanced Materials (2024) Vol. 36, Iss. 24
Closed Access | Times Cited: 26
A Comprehensive Review of Nanoparticles: From Classification to Application and Toxicity
Furkan Eker, Hatice Duman, Emir Akdaşçi, et al.
Molecules (2024) Vol. 29, Iss. 15, pp. 3482-3482
Open Access | Times Cited: 25
Chitosan nanoparticles as a smart nanocarrier for gefitinib for tackling lung cancer: Design of experiment and in vitro cytotoxicity study
Haitham Amin, Mohammed A. Amin, Shaaban K. Osman, et al.
International Journal of Biological Macromolecules (2023) Vol. 246, pp. 125638-125638
Closed Access | Times Cited: 21
c(RGDfK) anchored surface manipulated liposome for tumor-targeted tyrosine kinase inhibitor (TKI) delivery to potentiate liver anticancer activity
Payal Deepak, Praveen Kumar, Dilip Kumar Arya, et al.
International Journal of Pharmaceutics (2023) Vol. 642, pp. 123160-123160
Closed Access | Times Cited: 19
Revolutionizing lung health: Exploring the latest breakthroughs and future prospects of synbiotic nanostructures in lung diseases
Ayeh Bani Saeid, Gabriele De Rubis, Kylie A. Williams, et al.
Chemico-Biological Interactions (2024) Vol. 395, pp. 111009-111009
Open Access | Times Cited: 4
Soluble starch nanoparticles loaded with Gefitinib for treating lung cancer: Optimization and cytotoxicity assessment
Mohammed A. Amin, Hamdoon A. Mohammed
International Journal of Biological Macromolecules (2025), pp. 140369-140369
Closed Access
Preparation, Optimization, and In-Vitro Evaluation of Brusatol- and Docetaxel-Loaded Nanoparticles for the Treatment of Prostate Cancer
Tayo Alex Adekiya, Madison Moore, Michael A. Thomas, et al.
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 114-114
Open Access | Times Cited: 3
Formulation optimization and PK/PD evaluation of novel valsartan bilosomes enhancing transdermal drug delivery
Himabindu Peddapalli, Gadela Venkata Radha, Santhosh Kumar Chinnaiyan
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105400-105400
Closed Access | Times Cited: 3
Preparation and evaluation of biological activity of ZSM-5 nanoparticles loaded with gefitinib for the treatment of non-small cell lung carcinoma
Farah Al-Sahlawi, Israa Al‐Ani, Mohamed El‐Tanani, et al.
Pharmacia (2024) Vol. 71, pp. 1-12
Open Access | Times Cited: 3
“Revolutionizing Cancer Treatment: The Role of Starch‐Based Nanoparticles in Targeted Therapy”
Devesh U. Kapoor, Geeta Patel, Bhupendra G. Prajapati
Starch - Stärke (2025)
Closed Access
Formulation Development of Natural Polymeric Nanoparticles, In Vitro Antiaging Evaluation, and Metabolite Profiling of Toona sinensis Leaf Extracts
Uce Lestari, Muhaimin Muhaimin, Anis Yohana Chaerunisaa, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 288-288
Open Access
Tyrosine kinase inhibitor-loaded zein nanoparticles with enhanced drug delivery and anticancer efficacy
C. P. Jayalakshmi, Mohamed Haider, Pallab Sanpui
International Journal of Biological Macromolecules (2025), pp. 143898-143898
Closed Access
Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches
Susmita Aryal, Sanghyo Park, Hyungkyu Park, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 7865-7888
Open Access | Times Cited: 8
Capecitabine loaded potato starch-chitosan nanoparticles: A novel approach for targeted therapy and improved outcomes in aggressive colon cancer
Sankha Bhattacharya, Amit Page, Prafull Shinde
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 200, pp. 114328-114328
Closed Access | Times Cited: 3
Development of Gefitinib-Loaded Solid Lipid Nanoparticles for the Treatment of Breast Cancer: Physicochemical Evaluation, Stability, and Anticancer Activity in Breast Cancer (MCF-7) Cells
Ibrahim A. Aljuffali, Md. Khalid Anwer, Mohammed Muqtader Ahmed, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1549-1549
Open Access | Times Cited: 4
Amelioration of The Therapeutic Potential of Gefitinib Against Breast Cancer Using Nanostructured Lipid Carriers
Pankaj Kumar, Bharti Mangla, Shamama Javed, et al.
Nanomedicine (2023) Vol. 18, Iss. 18, pp. 1139-1160
Closed Access | Times Cited: 2
Recent Therapy to Treat Various Types of Cancer: An Overview
Amit Kumar, Rajesh Kumar, Ajeet Singh, et al.
Journal of Biomedical and Pharmaceutical Research (2024) Vol. 13, Iss. 1, pp. 68-83
Open Access
Green polymer‐based materials as promising therapeutical agents for non‐communicable diseases
Manuel Humberto Cháirez‐Ramírez, Jesús Omar Díaz-Rivas, Javier Isaac Contreras‐Ramírez, et al.
Polymer International (2024)
Closed Access
FORMULATION AND CHARACTERIZATION OF THERMOSENSITIVE CHITOSAN HYDROGEL LOADED WITH ERLOTINIB: FULL FACTORIAL DESIGN OF RELEASE DATA
Shaaban K. Osman, Arafat Abdelzaher, Ahmed M. Mohammed
˜Al-œAzhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences (2023) Vol. 68, Iss. 2, pp. 1-27
Open Access
Page 1

Scroll to top